Operator Good morning and welcome to the UnitedHealth Group fourth quarter and full year 2024 earnings conference call. A ...
Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...
After a dip in the wake of the release of UnitedHealth Group's Q4 2024 earnings figures, shares in the company and other ...
Designed by industry leader Clearlight®, the PERSONAL Red Light Therapy Tower (“the PERSONAL Tower”) shines bright as the mid-level wellness marvel that supports health, inside and out. The 2024 “Best ...
Sarah James; Analyst; Cantor Fitzgerald Joanna Gajuk; Analyst; BofA Global Research ...
Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?
China was producing tiles that were not easily available in the United States or from other parts ... (PBM Flooring) reads as follows, “Tile Council of North America Product Performance Testing ...
LITTLE ROCK, Ark. — High drug costs and struggling local pharmacies have become critical challenges for Arkansans. That reality is the very reason that's prompting lawmakers to take action ...
CVS Health owns Caremark and Cordavis, and its PBM's formulary contains a Cordavis-branded biosimilar. "Confusing? Absolutely. Profitable for the PBMs? Certainly. Good for plan sponsors and patients?
Douglas Hoey, said in a statement, “PBM reform would rein in the big health insurance lobby, save taxpayers $5 billion, and throw a lifeline to the thousands of small, family-owned pharmacies ...